CA2928464A1 - Biomarqueur de l'activite de melk et ses procedes d'utilisation - Google Patents
Biomarqueur de l'activite de melk et ses procedes d'utilisation Download PDFInfo
- Publication number
- CA2928464A1 CA2928464A1 CA2928464A CA2928464A CA2928464A1 CA 2928464 A1 CA2928464 A1 CA 2928464A1 CA 2928464 A CA2928464 A CA 2928464A CA 2928464 A CA2928464 A CA 2928464A CA 2928464 A1 CA2928464 A1 CA 2928464A1
- Authority
- CA
- Canada
- Prior art keywords
- human
- phosphorylated
- ortholog
- melk
- histone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57575—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving oncogenic proteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/91—Transferases (2.)
- G01N2333/912—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Organic Chemistry (AREA)
- Analytical Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Urology & Nephrology (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Cell Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361902877P | 2013-11-12 | 2013-11-12 | |
| US61/902,877 | 2013-11-12 | ||
| US201461954046P | 2014-03-17 | 2014-03-17 | |
| US61/954,046 | 2014-03-17 | ||
| PCT/US2014/065173 WO2015073509A2 (fr) | 2013-11-12 | 2014-11-12 | Biomarqueur de l'activité de melk et ses procédés d'utilisation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2928464A1 true CA2928464A1 (fr) | 2015-05-21 |
Family
ID=55867713
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2928464A Abandoned CA2928464A1 (fr) | 2013-11-12 | 2014-11-12 | Biomarqueur de l'activite de melk et ses procedes d'utilisation |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP3068930A4 (fr) |
| CN (1) | CN106232878A (fr) |
| AU (1) | AU2014348780B2 (fr) |
| CA (1) | CA2928464A1 (fr) |
| WO (1) | WO2015073509A2 (fr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN120741858A (zh) * | 2025-08-20 | 2025-10-03 | 四川大学华西医院 | 检测表观遗传修饰的h3t3的试剂的用途和表观遗传修饰的h3t3抑制剂的用途 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005016279A2 (fr) * | 2003-08-14 | 2005-02-24 | Exelixis, Inc. | Melks utilises comme modificateurs du mecanisme d'action de rac et procedes d'utilisation |
| EP2574929A1 (fr) * | 2011-09-28 | 2013-04-03 | IMG Institut für medizinische Genomforschung Planungsgesellschaft M.B.H. | Marqueur pour le diagnostic du cancer de la prostate |
| CN103173527A (zh) * | 2011-12-22 | 2013-06-26 | 上海生物芯片有限公司 | Melk基因的用途 |
| WO2013109388A2 (fr) * | 2012-01-19 | 2013-07-25 | Oncotherapy Science, Inc. | Dérivés de 1,5-naphtyridine et inhibiteurs de melk les contenant |
-
2014
- 2014-11-12 EP EP14862279.8A patent/EP3068930A4/fr not_active Withdrawn
- 2014-11-12 CA CA2928464A patent/CA2928464A1/fr not_active Abandoned
- 2014-11-12 CN CN201480072848.3A patent/CN106232878A/zh active Pending
- 2014-11-12 WO PCT/US2014/065173 patent/WO2015073509A2/fr not_active Ceased
- 2014-11-12 AU AU2014348780A patent/AU2014348780B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| EP3068930A2 (fr) | 2016-09-21 |
| WO2015073509A2 (fr) | 2015-05-21 |
| AU2014348780A8 (en) | 2016-06-30 |
| AU2014348780B2 (en) | 2018-12-13 |
| CN106232878A (zh) | 2016-12-14 |
| EP3068930A4 (fr) | 2017-10-04 |
| AU2014348780A1 (en) | 2016-06-02 |
| WO2015073509A3 (fr) | 2016-01-14 |
| WO2015073509A8 (fr) | 2016-05-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7169594B2 (en) | Diagnosis and treatment of diseases arising from defects in the tuberous sclerosis pathway | |
| EP2671954B1 (fr) | Translocation et kinase ROS mutante dans un cancer du poumon non à petites cellules chez un être humain | |
| US20080199896A1 (en) | Diagnosis and Treatment of Diseases Arising from Defects in the Tuberous Sclerosis Pathway | |
| HUE035769T2 (en) | Mutant ROS expression in human liver cancer | |
| Maccario et al. | Ubiquitination of PTEN (phosphatase and tensin homolog) inhibits phosphatase activity and is enhanced by membrane targeting and hyperosmotic stress | |
| US6416759B1 (en) | Antiproliferative Sgk reagents and methods | |
| US20040265931A1 (en) | HAUSP-Mdm2 interaction and uses thereof | |
| CN110237257B (zh) | Ube3a泛素化PP2A激活因子PTPA在治疗天使综合症和孤独症中的应用 | |
| US7364870B2 (en) | MK2 interacting proteins | |
| US8809500B2 (en) | Complexes comprising mammalian raptor polypeptide and mammalian mTOR polypeptide | |
| EP2526424A2 (fr) | Compositions, kits, et procédés d'identification, d'évaluation, de prévention, et de thérapie de troubles métaboliques | |
| EP1699460B1 (fr) | Utilisation d'inhibiteurs enzymatiques de h-prune pour la prevention et le traitement des metastases de tumeurs sur-exprimant h-prune | |
| KR20070091602A (ko) | p53-의존성 및 비의존성 종양 억제 매개체로서의ARF-BP1 및 그의 용도 | |
| US20060094013A1 (en) | Salt-inducible kinases 2 and use thereof | |
| US7193053B2 (en) | Hypoxia-inducible factor 1alpha variants and methods of use | |
| US10254283B2 (en) | Biomarker for MELK activity and methods of using same | |
| CA2928464A1 (fr) | Biomarqueur de l'activite de melk et ses procedes d'utilisation | |
| WO2004012755A1 (fr) | Methodes de regulation de l'activite d'un complexe renfermant brca1-brca2 | |
| WO2001091629A2 (fr) | Procedes permettant la detection d'adn endommage et la selection de therapeutiques anticancereux | |
| WO2012173841A1 (fr) | Biomarqueur pour une activité pkc-iota et procédés d'utilisation de celui-ci | |
| US20080193952A1 (en) | Inducible Nitric Oxide Synthase Binds, S-Nitrosylates, and Activates Cyclooxygenase-2 | |
| CA2431313A1 (fr) | Procede de diagnostic du cancer du sein et/ou du cancer colorectal, compositions, et procedes de criblage de modulateurs du cancer du sein et/ou du cancer colorectal | |
| US20100113557A1 (en) | Method for prevention of tumor | |
| WO2012133994A1 (fr) | Procédé de dépistage destiné à un agent de traitement du cancer utilisant une interaction entre le pauf et l'un de ses partenaires de liaison | |
| US20040072275A1 (en) | Interaction of NMDA receptor with protein tyrosine phosphatase |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued |
Effective date: 20210203 |